Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes

Stopped early · Phase 1

Conditions studied: Smoking Cessation

In brief

Eligible participants will be randomized to either: 1) standard care (i.e., 4 counseling sessions and nicotine replacement therapy (NRT)) or 2) standard care + contingency management (i.e., 4 counseling sessions and NRT + 3x/week meetings with positive reinforcers)

Key facts

Study ID

NCT01479998

Run by

Yale University

People needed

8

Starts

2011-11-01

Expected to finish

2013-06-01

Last updated by the study team

2020-03-09

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or older,
• smoking 5 or more cigarettes per day, and
• diagnosed with any type of head, neck, or thoracic cancer,
• agreement on a 3-week pre-surgical tobacco intervention by both patient and surgeon.

You may not qualify if…

• Unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia,
• history of allergic reactions to adhesives,
• females of childbearing potential who are pregnant, nursing, or not practicing effective contraception.

Where it is running

• Yale-New Haven Hospital — New Haven, Connecticut, United States
• Yale Cancer Center — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.